Business Wire

SIGFOX

19.5.2021 09:37:05 CEST | Business Wire | Press release

Share
Sabesp Delivers 92,000 Smart Water Meters Powered by the Sigfox 0G Network Operated by WND in Brazil

Sabesp, one of the largest water and sewage service providers in the world, today announces that it has successfully completed the implementation of 100,000 smart water meters with Internet of Things (IoT) technology. The project, which is one of the largest in Latin America, introduces water consumption telemeasurement in Sabesp's 100,000 largest consumers in the Metropolitan Region of São Paulo.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210519005356/en/

The Metrolink consortium is delivering the project and comprises of companies Laager and Vita Ambiental, which won the contract after a competitive bidding process Sabesp started at the end of 2018.

WND's Sigfox 0G network was the communication technology selected by Sabesp for more than 92,000 of the total connected water meters. WND is the exclusive operator of Sigfox technology in Brazil. Sigfox technology enables the transport of data wirelessly, at low cost, over long distances, with minimum energy consumption. The devices will be in operation for at least five years without changing or recharging the battery.

Telemetering – the remote reading of meters – automates the process of measuring water consumption. The task was performed manually once a month and can now be performed multiple times a day. In addition to measurement, the system also generates alarms and important statistics about the operation of the entire water network. All of these new features bring reliability, transparency and savings to consumers and unprecedented operational efficiency for Sabesp.

Ricardo Batista, Sabesp's Division Manager and responsible for the project, comments: "The project marked the large-scale adoption of the IoT concept by Sabesp. The new technology enables our customers to monitor water consumption daily, as well as leak detection, saving money and preserving the environment, in addition to better management of resources by our company. We hope to be able to expand the project in the coming years ."

According to Felipe Duque Estrada, CEO of Laager , the success of the project is largely due to the partnership with Sigfox and WND Brazil: "The adoption of 0G network technologies from Sigfox ensured the economic and technological viability of the project. "

José Almeida, Deputy CEO of WND Brazil , adds: "Thanks to Sabesp's pioneering approach, Laager's expertise and our work together, we have delivered one of the largest IoT projects in the Americas. The results achieved demonstrate, without any doubt, that our technology and business model are the best choices for IoT projects today. "

Carlos Beato, VP Americas at Sigfox concludes: “We are incredibly proud of SABESP’s achievement and visionary take on smart water metering. The benefits of such a solution go far beyond remote reading. It truly transforms the customer experience and Quality of Service. ”

*****

Sabesp – Companhia de Saneamento Básico do Estado de São Paulo (http://www.sabesp.com.br/ ) is the largest sanitation company in the Americas and the fourth largest in the world in the population served. It is responsible for the supply of water, sewage collection and treatment in 375 municipalities in the State of São Paulo, besides representing 30% of the investment in basic sanitation made in Brazil.

Laager Tecnologias Sustentáveis Ltda is a company specialized in technological solutions aimed at sustainability. Its devices make it possible to control the consumption of water, gas and electricity, besides allowing greater efficiency in consumption. The company has an advanced system of individualization of these resources, which can be applied to small, medium and large consumers.

Vita Ambiental is a traditional specialized Engineering Services provider for sanitation companies, focusing on reducing losses and operational optimizations.

WND Brazil , which is part of the WND Group (https://www.wndgroup.io/ ), operates in the IoT (Internet of Things) market through the implementation of a national public network, in a B2B (Business to Business) model that allows the sale of connectivity at low cost. In just three years of operation in Brazilian territory, the company is already present in all capital cities of the country, covering an area with a population of more than 120 million inhabitants and serving more than 360 cities. WND Brazil is a pioneer in a national public network dedicated exclusively to IoT using Sigfox technology.

Sigfox is the 0G network pioneer and the world’s leading IoT (Internet of Things) service provider. Sigfox offers a unique combination of ultra-low cost and ultra-low power technologies supported by a global network, enabling businesses to gain visibility and track their assets worldwide. With more than 17 million connected devices and 70 million messages sent a day, Sigfox helps its customers to extract crucial data at the lowest cost and to accelerate their digital transformation in key areas such as Asset Tracking and Supply Chain.

ISO 9001 certified and surrounded by a large ecosystem of partners and IoT key players, Sigfox was founded in 2010 and is headquartered in Labège, France, with offices in Boston, Dallas, Dubai, Madrid, Paris, Sao Paulo, Singapore and Tokyo.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye